Desk› Healthcare› Adline Chem Lab Ltd
Adline Chem Lab Ltd
Filing rhythm · 30 trading days
6 filings · 2 material · busiest 2026-08-13
What it files
Filings
6 in the window
-
24 August 2026
Board MeetingBoard Meeting Intimation for 38Th Annual General Meeting
Adline Chem Lab Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 ,inter alia, to consider and approve the day, date, time of 38th ....
Board Meeting / Board Meeting View filing →
-
14 August 2026
Newspaper PublicationNewspaper Publication
Newspaper Advertisment for Extract of Unaudited Standalone Financial Results for the Quarter ended 30th June 2026.
Company Update / Newspaper Publication View filing →
-
13 August 2026
Board OutcomeBoard Meeting Outcome for Board Meeting Outcome For Adline Chem Lab Limited For Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026.
Board Meeting Outcome for Adline Chem Lab Limited for Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
13 August 2026
ResultsUnaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2026.
unaudited Stanalone Financial Results of the Company for the Quarter Ended June 30, 2026.
Result / Financial Results View filing →
-
10 August 2026
Board MeetingBoard Meeting Intimation for For Considering And Approving Un-Audited Standalone Financial Results For The Quarter Ended On 30.06.2026.
Adline Chem Lab Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-audited Standalone Financial ....
Board Meeting / Board Meeting View filing →
-
15 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on June 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →